Clinical Trial Update: Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab for locally advanced or metastatic synovial sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Synovial Sarcoma

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Sarcoma | Phase 2 | Status: COMPLETED